Ensign Peak Advisors, Inc Novartis Ag Transaction History

Ensign Peak Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $9.37 Million - $10.4 Million	-114,017 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $3.12 Million - $3.51 Million	38,578 Added 51.14%	114,017 $9.96 Million
Q1 2020 May 11, 2020	SELL	$70.67 - $99.01 $1.48 Million - $2.08 Million	-21,009 Reduced 21.78%	75,439 $6.22 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $8.14 Million - $9.2 Million	96,448 New	96,448 $9.13 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.